MedTrace Logo

Study of Blood Samples From Newborns With Down Syndrome

NCT00959283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-10-03

No results posted yet for this study

Summary

This research study is looking at blood samples from newborns with Down syndrome. Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.

Conditions

  • Myeloid Proliferations Associated With Down Syndrome

Interventions

OTHER

Diagnostic Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • April D Sorrell · Children's Oncology Group

Eligibility

Max Age
90 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-23
Primary Completion
2011-12-30
Completion
2023-09-30

Countries

  • United States
  • Australia
  • Canada
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00959283 on ClinicalTrials.gov